Teza Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-364
Closed -$281K 507
2024
Q4
$281K Sell
364
-4,676
-93% -$3.87M 0.04% 368
2024
Q3
$4.47M Buy
5,040
+343
+7% +$308K 0.49% 48
2024
Q2
$4.25M Buy
+4,697
New +$3.76M 0.52% 38
2024
Q1
Sell
-5,983
Closed -$3.49M 669
2023
Q4
$3.49M Buy
5,983
+1,459
+32% +$852K 0.58% 34
2023
Q3
$2.43M Buy
+4,524
New +$2.33M 0.4% 58
2023
Q2
Sell
-1,057
Closed -$363K 657
2023
Q1
$363K Sell
1,057
-1,810
-63% -$610K 0.08% 337
2022
Q4
$1.05M Buy
+2,867
New +$1.02M 0.2% 163
2022
Q3
Sell
-7,005
Closed -$2.27M 586
2022
Q2
$2.27M Buy
+7,005
New +$2.1M 0.87% 6
2022
Q1
Sell
-8,814
Closed -$2.44M 473
2021
Q4
$2.44M Buy
+8,814
New +$2.23M 0.65% 32
2021
Q3
Sell
-2,943
Closed -$675K 478
2021
Q2
$675K Buy
+2,943
New +$591K 0.11% 249
2020
Q4
Sell
-2,545
Closed -$377K 371
2020
Q3
$377K Buy
+2,545
New +$394K 0.22% 163
2019
Q3
Sell
-4,255
Closed -$471K 562
2019
Q2
$471K Buy
+4,255
New +$501K 0.28% 122
2018
Q4
Sell
-28,934
Closed -$3.1M 411
2018
Q3
$3.1M Sell
28,934
-9,075
-24% -$907K 0.72% 25
2018
Q2
$3.24M Buy
+38,009
New +$3.12M 0.48% 41
2017
Q2
Sell
-21,700
Closed -$1.82M 208
2017
Q1
$1.82M Buy
+21,700
New +$1.74M 0.53% 34

Other funds holding LLY

Teza Capital Management's LLY Position: Q1 2025 in Review

Teza Capital Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 364 shares — an estimated $281K sold.

Teza Capital Management first reported a position in LLY in Q1 2017 and held it in 15 quarters. The position peaked at $4.47M in Q3 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Teza Capital Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Teza Capital Management sold 364 Eli Lilly shares in Q1 2025, an estimated $281K.
  • Teza Capital Management first reported a position in Eli Lilly in Q1 2017 and held it in 15 quarters.
  • Teza Capital Management's Eli Lilly position peaked at $4.47M in Q3 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Teza Capital Management's 13F filing for Q1 2025, filed 15 May 2025.